NEW YORK (GenomeWeb) – QuantuMDx and German microarray firm Scienion today announced that they have partnered to commercialize QuantuMDx's multiplexed nanowire array technology.

The nanowire technology is a component of QuantuMDx's Q-Poc handheld molecular diagnostic device. Molecular probes are printed on each nanowire in the array, raising multiplex potential.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.